VivoSim Labs VIVS
NASDAQ VIVS
$0.29 +0.01 (+3.06%)
At close: Aug 21, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Non Operating Income (2011 - 2026)

VivoSim Labs (VIVS) posted quarterly Non Operating Income of -$2.6 million for Q1 2026, down 125.75% year-over-year from $10.0 million in Q1 2025, and down 4467.8% quarter-over-quarter from $59000.0 in Q4 2025.

VivoSim Labs (VIVS) Non Operating Income (2011 - 2026) Analysis & Trends

VivoSim Labs' Non Operating Income history runs 16 years deep, the most recent figure standing at -$2.6 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 125.75% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$2.4 million (down 123.24% YoY), while the FY2026 annual figure was -$2.4 million, down 123.24% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$2.6 million, down from $59000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $10.0 million in Q1 2025, with the low at -$2.6 million in Q1 2026.
  • The 5-year median for Non Operating Income is $59000.0 (2024), against an average of $509941.2.
  • The sharpest annual moves came in 2025 and 2026: Non Operating Income soared 19519.61% in 2025, then slumped 125.75% in 2026.
  • VivoSim Labs' Non Operating Income stood at $95000.0 in 2022, then slipped by 20.0% to $76000.0 in 2023, then tumbled by 72.37% to $21000.0 in 2024, then surged by 180.95% to $59000.0 in 2025, then plunged by 4467.8% to -$2.6 million in 2026.
  • Business Quant data shows VIVS's Non Operating Income at -$2.6 million in Q1 2026, $59000.0 in Q4 2025, and $92000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -53.64 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -51.63 Mn
10 VivoSim Labs 1.49 Mn 1.49 Mn - 1.42 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.42 Mn
Mar 31, 2026 -2.58 Mn
Dec 31, 2025 59,000.00
Sep 30, 2025 92,000.00
Jun 30, 2025 72,000.00
Mar 31, 2025 10.01 Mn
Dec 31, 2024 21,000.00
Sep 30, 2024 59,000.00
Jun 30, 2024 44,000.00
Mar 31, 2024 51,000.00
Dec 31, 2023 76,000.00
Sep 30, 2023 121,000.00
Jun 30, 2023 169,000.00
Mar 31, 2023 320,000.00
Dec 31, 2022 95,000.00
Sep 30, 2022 33,000.00
Jun 30, 2022 26,000.00
Mar 31, 2022 2,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 2,000.00